BMRN — BIOMARIN PHARMACEUTICAL INC
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
截至Q2 2026,共 596 家机构在其最新 13F 申报中持有 BMRN(BIOMARIN PHARMACEUTICAL INC),合计申报市值 $12.29B,对应 527.79M 股。按股数计算较上季度减持 18.3%(-113.72M 股),申报市值环比上升 13.5%。持仓集中度较高:前五大持有人占申报市值的 31.9%,前十大的集中度为 49.7%。
与上一季度相比,86 家新建仓位、194 家加仓、194 家减仓、83 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。
BIOMARIN PHARMACEUTICAL INC(BMRN)的主要机构持有人包括 Shaolin Capital Management LLC、Vanguard Group、PRIMECAP MANAGEMENT CO/CA/,按 13F 申报市值在本页 1172 家持有人中排名居前。
BMRN 属于Health Care板块。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
持有 BMRN 的传奇投资人
我们追踪的超级投资人在各自最新 13F 申报中持有 BMRN 的名单——每位投资人按其自身最近一个季度展示。
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 447 | 823.40M | $6.01B | +5.4% |
| Q2 2026 | 596 | 527.79M | $12.29B | -18.0% |
| Q1 2026 | 591 | 637.70M | $10.11B | -1.1% |
| Q4 2025 | 575 | 646.46M | $10.66B | +11.0% |
| Q3 2025 | 601 | 597.31M | $9.64B | +16.7% |
| Q2 2025 | 607 | 502.88M | $9.92B | -1.1% |
| Q1 2025 | 599 | 430.93M | $13.00B | +16.2% |
| Q4 2024 | 556 | 369.12M | $26.76B | +3.5% |
表内 8 个季度中,机构持股合计增加 123%(Q4 2024 → Q3 2026);单季变动最大的是 Q2 2026(-18.0%)。
前 25 大机构持仓人(Q3 2026) — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 14.99M | $899.34M | 0.56% | 增持 | |
| 14.63M | $877.54M | 0.47% | 减持 | |
| 8.72M | $523.42M | 0.01% | 持有 | |
| 8.37M | $502.31M | 0.02% | 减持 | |
| 7.34M | $440.58M | 0.02% | 增持 | |
| 4.40M | $263.93M | 0.05% | 增持 | |
| 3.76M | $225.36M | 0.01% | 减持 | |
| 3.56M | $213.52M | 0.03% | 增持 | |
| 1.92M | $114.91M | 0.07% | 增持 | |
| 1.48M | $88.60M | 0.07% | 增持 | |
| 1.34M | $80.37M | 0.10% | 减持 | |
| 1.23M | $73.63M | 0.02% | 持有 | |
| 1.22M | $73.04M | 0.19% | 减持 | |
| 1.17M | $70.31M | 11.93% | 减持 | |
| 1.13M | $67.97M | 0.01% | 减持 | |
| 1.16M | $66.00M | 0.01% | 增持 | |
| 750.00K | $45.00M | 0.38% | 减持 | |
| 737.54K | $44.25M | 1.12% | 减持 | |
| 727.77K | $43.67M | 0.06% | 增持 | |
| 712.88K | $42.77M | 0.53% | 增持 | |
| 712.05K | $42.72M | 0.22% | 减持 | |
| 691.89K | $41.51M | 0.01% | 持有 | |
| 616.00K | $36.96M | 0.13% | 减持 | |
| 565.56K | $33.93M | 0.04% | 减持 | |
| 525.27K | $31.52M | 0.00% | 增持 |
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 25 家基金
Q1 2026 — 25 家基金
Q4 2025 — 25 家基金
Q3 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 18.58M | $1.01B | 0.01% | 减持 | |
| 15.23M | $824.82M | 0.63% | 减持 | |
| 14.69M | $795.44M | 0.43% | 减持 | |
| 14.69M | $795.44M | 0.43% | 减持 | |
| 8.32M | $450.73M | 1.17% | 减持 | |
| 8.32M | $450.73M | 1.17% | 减持 | |
| 5.93M | $321.28M | 0.21% | 增持 | |
| 5.93M | $321.28M | 0.21% | 增持 | |
| 5.06M | $273.99M | 0.03% | 增持 | |
| 3.54M | $191.29M | 0.01% | 增持 | |
| 2.54M | $137.44M | 0.03% | 增持 | |
| 2.54M | $137.44M | 0.03% | 增持 | |
| 2.29M | $124.08M | 0.05% | 增持 | |
| 2.25M | $121.60M | 0.03% | 增持 | |
| 1.89M | $102.56M | 0.14% | 增持 | |
| 102.08M | $97.51M | 1.95% | 增持 | |
| 1.66M | $90.03M | 0.01% | 持有 | |
| 1.49M | $80.88M | 0.25% | 增持 | |
| 1.40M | $75.69M | 0.01% | 减持 | |
| 1.40M | $75.69M | 0.01% | 减持 | |
| 1.87M | $74.81M | 0.02% | 增持 | |
| 1.33M | $72.16M | 0.24% | 增持 | |
| 1.27M | $69.02M | 0.26% | 增持 | |
| 1.26M | $66.57M | 0.02% | 减持 | |
| 1.09M | $58.82M | 0.02% | 增持 |
Q2 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 19.00M | $1.04B | 0.02% | 持有 | |
| 15.77M | $867.00M | 0.69% | 减持 | |
| 15.11M | $830.50M | 0.47% | 增持 | |
| 15.11M | $830.50M | 0.47% | 增持 | |
| 12.29M | $675.50M | 1.95% | 增持 | |
| 12.29M | $675.50M | 1.95% | 增持 | |
| 5.58M | $306.43M | 0.25% | 增持 | |
| 5.58M | $306.43M | 0.25% | 增持 | |
| 3.47M | $190.42M | 0.01% | 增持 | |
| 2.85M | $156.54M | 0.08% | 增持 | |
| 2.19M | $118.71M | 0.04% | 减持 | |
| 2.11M | $115.75M | 0.05% | 增持 | |
| 2.04M | $112.35M | 0.01% | 减持 | |
| 1.81M | $99.32M | 0.13% | 增持 | |
| 1.66M | $90.98M | 0.01% | 减持 | |
| 1.57M | $86.51M | 0.02% | 增持 | |
| 1.56M | $85.54M | 0.01% | 增持 | |
| 1.56M | $85.54M | 0.01% | 增持 | |
| 1.48M | $81.19M | 0.27% | 增持 | |
| 1.67M | $75.35M | 0.02% | 减持 | |
| 77.58M | $73.28M | 1.36% | 新进 | |
| 1.32M | $72.55M | 0.01% | 增持 | |
| 1.18M | $64.61M | 0.05% | 增持 | |
| 1.12M | $61.53M | 0.26% | 增持 | |
| 1.09M | $60.14M | 0.06% | 增持 |
新建仓(Q2 2026)
- GEODE CAPITAL MANAGEMENT, LLC 3.91M 股 · $223.89M
- Sixth Street Partners Management Company, L.P. 1.62M 股 · $92.47M
- ARGA Investment Management, LP 1.04M 股 · $59.47M
- Defilade Capital Management, L.P. 682.00K 股 · $39.02M
- Trails Edge Capital Partners, LP 512.00K 股 · $29.30M
- HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 447.20K 股 · $25.59M
- Distillate Capital Partners LLC 248.92K 股 · $14.24M
- TCW GROUP INC 193.65K 股 · $11.08M
- Boston Partners 153.45K 股 · $8.78M
- Apollon Wealth Management, LLC 137.66K 股 · $7.88M
- Schonfeld Strategic Advisors LLC 103.19K 股 · $5.90M
- Marshall Wace 97.30K 股 · $5.57M
完全清仓(较上季)
- Novo Holdings A/S 卖出 660.00K 股 · $37.28M
- BRAIDWELL LP 卖出 497.02K 股 · $28.08M
- Rubric Capital Management LP 卖出 440.56K 股 · $24.89M
- LMR Partners LLP 卖出 324.94K 股 · $18.36M
- CIBC Bancorp USA Inc. 卖出 207.80K 股 · $11.74M
- STATE STREET CORP 卖出 11.57M 股 · $11.18M
- Sio Capital Management, LLC 卖出 194.23K 股 · $10.97M
- CWM, LLC 卖出 159.65K 股 · $9.02M
- Point72 Asset Management 卖出 100.00K 股 · $5.65M
- SCHRODER INVESTMENT MANAGEMENT GROUP 卖出 56.33K 股 · $3.18M
- Taproot Management LP 卖出 49.34K 股 · $2.79M
- CAXTON ASSOCIATES LLP 卖出 49.31K 股 · $2.79M
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PRIMECAP MANAGEMENT CO/CA/ | 14.99M | 14.19M | 14.19M | 14.55M | 15.23M | 15.77M | 17.77M | 18.19M | 18.87M | 18.79M | 18.71M | 18.41M | 18.41M | — | — | — | — | — | — | — |
| DODGE & COX | 14.63M | 14.84M | 14.56M | 14.57M | 14.69M | 15.11M | 14.96M | 14.75M | 13.90M | 13.93M | 13.99M | 13.99M | 14.15M | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 8.72M | 8.74M | 8.64M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 8.37M | 8.65M | 8.30M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Fidelity Management & Research (FMR) | 7.34M | 4.82M | 3.57M | 1.84M | 392.81K | 546.10K | 541.51K | 238.16K | 206.54K | 169.66K | 486.48K | 1.07M | 713.80K | 547.58K | 551.65K | 465.27K | 684.01K | 514.28K | 265.45K | 181.22K |
| DIMENSIONAL FUND ADVISORS LP | 4.40M | 4.08M | 3.80M | 3.32M | 2.25M | 1.57M | 1.17M | 1.15M | 1.34M | 1.03M | 744.50K | 704.95K | 633.10K | — | — | — | — | — | — | — |
| Geode Capital Management | 3.76M | 3.91M | 3.82M | 3.67M | 3.54M | 3.47M | 3.43M | 3.29M | 3.26M | 3.20M | 2.99M | 2.87M | 2.76M | 2.71M | 2.66M | 2.58M | 2.51M | 2.47M | 2.45M | 2.40M |
| Capital Research Global Investors | 3.56M | 3.50M | 3.49M | 2.55M | 2.54M | 391.88K | 9.15M | 12.99M | 10.49M | 9.69M | 6.52M | 10.77M | 6.02M | — | — | — | — | — | — | — |
| FIRST TRUST ADVISORS LP | 1.92M | 1.61M | 1.67M | 1.17M | 894.96K | 738.48K | 669.48K | 629.99K | 467.30K | 404.02K | 476.53K | 579.93K | 523.40K | — | — | — | — | — | — | — |
| Swedbank AB | 1.48M | 1.31M | 792.19K | 796.74K | 466.94K | 431.94K | 429.84K | 432.12K | 388.53K | 288.53K | 296.13K | 466.23K | 507.03K | — | — | — | — | — | — | — |
| Assenagon Asset Management S.A. | 1.34M | 1.76M | 1.92M | 1.42M | 344.14K | 1.04M | 809.12K | 611.67K | 108.97K | 352.47K | 3.15K | 16.99K | 103.08K | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 1.23M | 1.22M | 1.19M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| DnB Asset Management AS | 1.22M | 1.27M | 1.22M | 1.36M | 1.27M | 1.12M | 991.49K | 993.17K | 1.07M | 1.02M | 867.19K | 745.51K | 856.67K | — | — | — | — | — | — | — |
| Jones Hill Capital LP | 1.17M | 1.43M | 1.27M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| BNY Mellon | 1.13M | 1.16M | 1.14M | 1.78M | 1.87M | 1.67M | 1.68M | 2.70M | 2.62M | 2.64M | 2.94M | 2.86M | 2.60M | 2.39M | 2.38M | 550.00K | 1.45M | 1.65M | 1.19M | 1.15M |
| Franklin Resources | 1.16M | 936.04K | 933.88K | 95.10K | 5.71M | 8.42M | 9.02M | 9.02M | 8.80M | 5.01M | 5.11M | 301.76K | 566.24K | 836.23K | 685.29K | 332.13K | 445.73K | 443.19K | 441.90K | 527.25K |
| Hudson Bay Capital Management LP | 750.00K | 825.00K | 974.78K | 670.00K | 693.89K | 526.42K | 586.85K | 460.00K | 441.20K | 244.70K | 109.90K | 74.61K | 130.91K | — | — | — | — | — | — | — |
| ARGA Investment Management, LP | 737.54K | 1.04M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Renaissance Technologies | 727.77K | 451.87K | 1.02M | 1.32M | 1.89M | 1.81M | 895.77K | 435.87K | 418.87K | 116.20K | 542.07K | 386.67K | 581.77K | 732.64K | 781.07K | 630.27K | 744.47K | 734.76K | 491.17K | 651.06K |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 712.88K | 687.03K | 686.03K | 664.53K | 677.39K | 649.42K | 563.53K | 563.53K | 413.23K | 80.00K | 1.12M | 1.12M | 1.12M | — | — | — | — | — | — | — |
▲ 低买(基金新建/增持,下一季股价上涨 ≥5%) ▼ 高卖(基金减持,下一季股价下跌 ≥5%)
拖拽/滚轮缩放 · 默认显示最近一年 · 标注来自 13F 申报中的季度基金操作 · 悬停查看详情
常见问题
Which funds hold BMRN?
As of 2026-Q2, 596 institutional funds reported holding BMRN (BIOMARIN PHARMACEUTICAL INC) in SEC 13F filings, with a combined reported value of $12.29B.
How many shares of BMRN do institutions own?
13F filers reported 527.79M shares of BMRN, worth $12.29B in aggregate at the end of 2026-Q2.
Is institutional ownership of BMRN rising or falling?
Share counts moved -18.3% versus the prior quarter — distribution.
Who are the top institutional holders of BMRN?
The largest 13F holders are Shaolin Capital Management LLC, Vanguard Group, PRIMECAP MANAGEMENT CO/CA/, DODGE & COX, Dodge & Cox; the top 25 are ranked at the top of this page.
Who are the major shareholders of BIOMARIN PHARMACEUTICAL INC?
The major shareholders of BIOMARIN PHARMACEUTICAL INC (BMRN) by reported 13F value are Shaolin Capital Management LLC, Vanguard Group, PRIMECAP MANAGEMENT CO/CA/, DODGE & COX, Dodge & Cox, among 1172 institutional holders.
Which legendary investors own BMRN?
4 of the legendary investors tracked on HoldingsHub report BMRN (BIOMARIN PHARMACEUTICAL INC) in their latest 13F filings, led by Dodge & Cox, Viking Global Investors, Howard Marks, Torray Funds. Each is shown at that manager's own most recent quarter.
Do superinvestors agree on BMRN?
4 tracked superinvestors hold BMRN simultaneously — see the consensus page for the stocks they own together.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.